AIBTRUST Selected for Tokyo-Supported 'Tokyo-Silicon Valley MedTech Launchpad' Program for US Market Entry
NQ Score
42/100
N1 Content Completeness
4
AI Summary (NQ-processed)
AIBTRUST has been selected for the Tokyo-supported 'Tokyo-Silicon Valley MedTech Launchpad' program. This will enable the company to verify the business potential of its medical DX solutions and next-generation medical registry platform business in the US market, accelerating its global expansion.